Related sites
الخط الساخن للخدمات الصحية للنازحين اللبنانيين 1787   
الخط الساخن لدخول المرضى الى المستشفيات 01/832700   
التسجيل لأخذ لقاح الكورونا covax.moph.gov.lb   
الخط الساخن لوزارة الصحّة العامة 1214   
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

الدعم النفسي للمعالجين ومرضاهم في أوقات الصراعات

 
The inaugural webinar from the 2025 first-quarter series, Healing the Healers – Supporting Yourself and Your Patients in the Aftermath of Conflict was held on Wednesday, January 22, 2025.

Organized under the partnership between the Ministry of Public Health (MoPH), the Australian Lebanese Medical Association (ALMA), and the International Organization for Migration (IOM), along with the support of the International Lebanese Medical Association (ILMA) and founding director of the National Mental Health Program (NMHP) at the Ministry, this impactful session hosted three distinguished guest speakers that addressed the mental health challenges faced by Lebanon’s medical teams during the recent emergency response.

Through sharing practical strategies, updated studies and guidelines, and personal experiences tailored to the Lebanese medical community, this webinar offered valuable insights, enhancing the capability to overcome the mental health repercussions of conflict and supporting both personal and professional growth in that area among participants.

If you missed the live session, you could still watch it here: https://www.youtube.com/watch?v=LepJ_ttqj0U

Save the Date for Webinar 2!
Next up: The Role of Telemedicine/Telehealth in Overcoming Healthcare Access Barriers.
Wednesday, February 26, 2025
8:00 – 9:30 PM Beirut Time
 
ATC Name B/G Ingredients Dosage Form Price
L01ED01 XALKORI B Crizotinib - 250mg 250mg Capsule L.L
A16AB02 CEREZYME B Imiglucerase - 400IU 400IU Injectable lyophilised powder for solution L.L
L04AA27 SCLEMOD G Fingolimod Hydrochloride - 0.5mg 0.5mg Capsule L.L
L04AD02 PROGRAF 0.5 MG B Tacrolimus - 0.5mg 0.5mg Capsule L.L
L04AD02 PROGRAF 1MG B Tacrolimus - 1mg 1mg Capsule L.L
L04AD02 PROGRAF 5MG B Tacrolimus - 5mg 5mg Capsule L.L
B02BX06 HEMLIBRA BioTech Emicizumab - 30mg/ml 30mg/ml Injectable solution L.L
L01EA04 BOSULIF B Bosutinib - 400mg 400mg Tablet, film coated L.L
L01EA04 BOSULIF B Bosutinib - 500mg 500mg Tablet, film coated L.L
L04AX04 REVLIMID B Lenalidomide - 10mg 10mg Capsule L.L
B02BX05 REVOLADE B Eltrombopag Olamine - 50mg 50mg Tablet, film coated L.L
L01FF03 IMFINZI BioTech Durvalumab - 500mg/10ml 500mg/10ml Injectable solution L.L
L01EF01 PAPILLIO G Palbociclib - 100mg 100mg Capsule, hard L.L
L01EX08 LENVIMA B Lenvatinib - 10mg 10mg Capsule, hard L.L
L01EX08 LENVIMA B Lenvatinib - 4mg 4mg Capsule, hard L.L
L02BX03 ABLAX 250 G Abiraterone acetate - 250mg 250mg Tablet L.L
L02BX03 ABLAX 500 G Abiraterone acetate - 500mg 500mg Tablet L.L
L01EF01 PALBRANCE 125 G Palbociclib - 125mg 125mg Capsule L.L
L01FX14 POLIVY BioHuman Polatuzumab vedotin - 140mg 140mg Injectable powder for concentrate for solution L.L
J06BA02 IMMUNOREL BioHuman Human normal immunoglobulin - 5g/100ml 5% Injectable solution L.L
L01XK01 LYNPARZA B Olaparib - 150mg 150mg Tablet, film coated L.L
L02AE04 DECAPEPTYL SR B Triptorelin (pamoate) - 3mg 3mg Injectable powder for suspension+diluent L.L
H01CB03 SOMATULINE AUTOGEL B Lanreotide (acetate) - 120mg 120mg Injectable solution L.L
V03AC03 JADENU B Deferasirox - 360mg 360mg Tablet, film coated L.L
M09AX10 EVRYSDI B Risdiplam - 0.75mg/ml 0.75mg/ml Powder L.L
B02BX06 HEMLIBRA BioTech Emicizumab - 60mg/0.4ml 60mg/0.4ml Injectable solution L.L
L04AA36 OCREVUS BioTech Ocrelizumab - 300mg/10ml 300mg/10ml Injectable concentrate for solution L.L
S01LA09 VABYSMO B Faricimab - 6mg/0.05ml 6mg/0.05ml Injectable solution L.L
L03AB11 PEGASYS BioTech Peginterferon alfa-2a - 180mcg/0.5ml 180mcg/0.5ml Injectable solution L.L
R03DX10 FASENRA B Benralizumab - 30mg 30mg Injectable solution L.L
Sitemap
© Copyrights reserved to Ministry of Public Health 2025